TARGIT IORT for breast cancer patients with low risk of recurrence

Suitable for Intrabeam TARGIT IORT as the sole treatment

Discuss in multidisciplinary team

Offer Intrabeam TARGIT IORT as the definitive radiotherapy*

*In 15-20% of cases, in if high risk factors are seen postoperatively, then whole breast radiotherapy (without a tumour bed boost) should be recommended